Contents

Current Medicinal Chemistry - Anti-Cancer Agents, Volume 3 - Number 3

Drugs Acting on the Beta Isoform of Human Topoisomerase II (p180)

, 3(3): 173 - 185

B. Gatto and E. Leo


DOI: 10.2174/1568011033482486




The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells

, 3(3): 187 - 199

Wei-Guo Zhu and Gregory A. Otterson


DOI: 10.2174/1568011033482440




Signal Transduction Inhibitors in the Treatment of Breast Cancer

, 3(3): 201 - 216

Rita Nahta, Gabriel N. Hortobagyi and Francisco J. Esteva


DOI: 10.2174/1568011033482468




The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics

, 3(3): 217 - 223

WenJing Liu, Anca Bulgaru, Missak Haigentz, C. A. Stein, Roman Perez-Soler and Sridhar Mani


DOI: 10.2174/1568011033482459




Pharmacogenetics of Irinotecan

, 3(3): 225 - 237

G. Toffoli, E. Cecchin, G. Corona and M. Boiocchi


DOI: 10.2174/1568011033482477




Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents

, 3(3): 239 - 251

S. Theocharis, A. Margeli and G. Kouraklis


DOI: 10.2174/1568011033482431




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science